BioLineRx Reports First Quarter 2019 Financial Results and Provides Corporate Update
Go back to BioLineRx Reports First Quarter 2019 Financial Results and Provides Corporate Update| BIOLINE RX SP ADR (NASDAQ: BLRX) | Delayed: 2.51 +0.03 (1.21%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.48 | 52 Week High | $1.63 | |||
| Open | $2.48 | 52 Week Low | $0.71 | |||
| Day High | $2.60 | P/E | N/A | |||
| Day Low | $2.48 | EPS | $0.00 | |||
| Volume | 2,424 | |||||
| BIOLINE RX SP ADR (NASDAQ: BLRX) | Delayed: 2.51 +0.03 (1.21%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.48 | 52 Week High | $1.63 | |||
| Open | $2.48 | 52 Week Low | $0.71 | |||
| Day High | $2.60 | P/E | N/A | |||
| Day Low | $2.48 | EPS | $0.00 | |||
| Volume | 2,424 | |||||

